Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uzedy (TV-46000) in Schizophrenia
NCT03503318Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Apr 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of risperidone in schizophrenia, sponsored by Teva Pharmaceutical Industries Ltd.. Started Apr 2018; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03503318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503318.